By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Investment bank Goldman Sachs today revised revenue and earnings per share estimates for Illumina for the next three years to "reflect our updated view on quarterly revenue pacing, recent financing activities, and corresponding share repurchase."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.